A 6-year-old child admitted with tonsillitis and snoring, negative C-reactive protein, normal chest examination, neutrophil-predominant complete blood count, who received two days of intravenous amoxicillin‑clavulanate (Augmentin) and then intravenous ceftriaxone but remains febrile, how should this be managed?

Management of Persistent Fever in a 6-Year-Old with Tonsillitis Despite Augmentin and Ceftriaxone

Add vancomycin or clindamycin immediately to cover community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), and perform further investigation including blood cultures, throat culture, and imaging to rule out complications such as peritonsillar abscess or retropharyngeal abscess.

Immediate Diagnostic Workup

This child has failed two appropriate first-line antibiotics (augmentin for 2 days, ceftriaxone for at least 1 day) and remains febrile beyond 48-72 hours of therapy. According to pediatric pneumonia guidelines, children who show no improvement within 48-72 hours require further investigation 1.

Essential Investigations Now:

• Blood cultures before adding new antibiotics
• Throat culture with sensitivity testing to identify resistant organisms
• Lateral neck X-ray or CT scan to evaluate for:
  • Peritonsillar abscess
  • Retropharyngeal abscess
  • Parapharyngeal extension
• Complete blood count with differential (already showing neutrophil predominance, but reassess)
• Repeat CRP or obtain ESR (negative CRP is unusual for bacterial infection but can occur early)

Antibiotic Management

Add Coverage for CA-MRSA Immediately

The persistent fever despite adequate beta-lactam coverage (augmentin then ceftriaxone) raises concern for:

1. CA-MRSA - increasingly common in severe tonsillitis
2. Resistant Streptococcus pyogenes
3. Suppurative complications (abscess formation)

Recommended antibiotic addition 1:

• Vancomycin 40-60 mg/kg/day IV every 6-8 hours (preferred for CA-MRSA)
  • OR Clindamycin 40 mg/kg/day IV every 6-8 hours (if local susceptibility patterns support this)

Continue the ceftriaxone alongside the new agent to maintain broad coverage until culture results return.

Why This Child Failed Initial Therapy

Augmentin Failure Analysis:

The child received only 2 days of augmentin IV before switching. While augmentin provides excellent coverage for typical tonsillitis pathogens (Streptococcus pyogenes, Haemophilus influenzae), the rapid switch suggests either:

• Inadequate dosing (should be 90 mg/kg/day of amoxicillin component) 2
• Resistant organism
• Wrong diagnosis (viral with bacterial superinfection)
• Complication development

Ceftriaxone Failure Analysis:

Ceftriaxone at 50-100 mg/kg/day provides excellent coverage for Streptococcus pneumoniae and most respiratory pathogens 3. Failure after appropriate dosing strongly suggests:

• CA-MRSA (ceftriaxone has no MRSA coverage)
• Abscess formation requiring drainage
• Non-bacterial etiology (EBV, other viral)

Critical Pitfalls to Avoid

The Negative CRP Paradox:

A negative CRP with neutrophil-predominant CBC and persistent fever is unusual. This could indicate:

• Very early infection (CRP rises 6-12 hours after onset)
• Viral infection with bacterial superinfection
• Localized infection (abscess) without systemic inflammation yet
• Lab error - consider repeating

Do not be falsely reassured by negative CRP in a febrile, ill-appearing child 4.

Snoring as a Red Flag:

The history of snoring suggests tonsillar hypertrophy, which increases risk for:

• Peritonsillar abscess
• Airway compromise if abscess develops
• Deep space neck infections

Monitor airway closely and have ENT consultation available.

Surgical Consultation Threshold

Obtain ENT consultation now if any of the following:

• Trismus (difficulty opening mouth)
• Drooling or difficulty swallowing
• Muffled "hot potato" voice
• Unilateral tonsillar swelling with uvular deviation
• Respiratory distress
• Imaging shows abscess

Surgical drainage may be required for peritonsillar or retropharyngeal abscess, which antibiotics alone cannot treat effectively.

Monitoring Parameters

While awaiting culture results and imaging:

• Temperature every 4 hours
• Oxygen saturation continuous monitoring
• Airway assessment every 2-4 hours (stridor, drooling, respiratory distress)
• Fluid status (ensure adequate hydration, NPO if surgery anticipated)
• Pain control (adequate analgesia improves oral intake)

Expected Timeline for Improvement

After adding vancomycin/clindamycin:

• Fever should defervesce within 24-48 hours if appropriate coverage achieved
• Clinical improvement (decreased throat pain, improved oral intake) within 48-72 hours
• If no improvement by 48 hours on vancomycin/clindamycin, strongly consider:
  • Surgical drainage of occult abscess
  • Alternative diagnosis (infectious mononucleosis, Lemierre syndrome, Kawasaki disease)
  • Immunodeficiency workup 5

Duration of Therapy

Once organism identified and appropriate antibiotic selected:

• Uncomplicated tonsillitis: 10 days total 6, 7
• With abscess: 14-21 days depending on clinical response
• CA-MRSA: Continue until afebrile for 48-72 hours and clinically improved, minimum 10-14 days

The key principle: this child has already failed standard therapy and requires escalation of both diagnostic workup and antibiotic coverage immediately, with low threshold for surgical intervention.